Under review simply means the FDA is still assessing: Safety Clinical relevance Regulatory appropriateness It does not mean: The peptide is approved The peptide is widely available The peptide is appropriate for general use At this stage, access to many of these substances may remain limited, inconsistent, or restricted, and quality can vary outside regulated pathways
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments
However, discuss any concerns with a doctor to prevent unwanted health issues
Gluten, dairy, soy, artificial colors, GMOs, and synthetic preservatives
10.1177/15648265080292S129 16 DelRe A